Literature DB >> 17179224

Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation.

Matthew Thomas1, Marco Calamito, Bhaskar Srivastava, Ivan Maillard, Warren S Pear, David Allman.   

Abstract

How diverse environmental cues are integrated to regulate B-cell activation and development remains poorly understood. Here we show that Notch activity synergizes with B-cell receptor (BCR) and/or CD40 signaling to enhance several aspects of B-cell activation and function. We find that costimulation of follicular B cells with the Notch ligand Delta-like-1 leads to significant increases in BCR- and CD40-mediated proliferation and enhances production of IgG1(+) cells in vitro and in vivo. We further find that coengagement of Notch and the BCR results in increased activation of the MAPK pathway, and MAPK and Notch inhibitors prevent B-cell activation events mediated by coengagement of Notch and the BCR. These data suggest that the BCR and CD40 signaling pathways collaborate with the Notch pathway to optimize B-cell activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179224     DOI: 10.1182/blood-2006-09-046698

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

Review 1.  The double-edged sword of Notch signaling in cancer.

Authors:  Andrew P South; Raymond J Cho; Jon C Aster
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

2.  B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33.

Authors:  Hiroshi Arima; Momoko Nishikori; Yasuyuki Otsuka; Wataru Kishimoto; Kiyotaka Izumi; Koubun Yasuda; Tomohiro Yoshimoto; Akifumi Takaori-Kondo
Journal:  Blood Adv       Date:  2018-09-25

Review 3.  Peripheral B cell subsets.

Authors:  David Allman; Shiv Pillai
Journal:  Curr Opin Immunol       Date:  2008-04-21       Impact factor: 7.486

4.  Ikaros in B cell development and function.

Authors:  Maclean Sellars; Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

5.  Notch1 is an important mediator for enhancing of B-cell activation and antibody secretion by Notch ligand.

Authors:  Jung-Ah Kang; Woo-Seok Kim; Sung-Gyoo Park
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

6.  Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation.

Authors:  Amy L Radke; Lauren E Reynolds; Rossana C N Melo; Ann M Dvorak; Peter F Weller; Lisa A Spencer
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

7.  Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells.

Authors:  Margarida Almeida Santos; Leonor Morais Sarmento; Manuel Rebelo; Ana Agua Doce; Ivan Maillard; Alexis Dumortier; Helia Neves; Freddy Radtke; Warren S Pear; Leonor Parreira; Jocelyne Demengeot
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

8.  Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashion.

Authors:  Lynn M Heltemes-Harris; Patricia J Gearhart; Paritosh Ghosh; Dan L Longo
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

9.  ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.

Authors:  David R Gibb; Mohey El Shikh; Dae-Joong Kang; Warren J Rowe; Rania El Sayed; Joanna Cichy; Hideo Yagita; John G Tew; Peter J Dempsey; Howard C Crawford; Daniel H Conrad
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

10.  An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

Authors:  Jonathan C Poe; Wei Jia; Hsuan Su; Sarah Anand; Jeremy J Rose; Prasanthi V Tata; Amy N Suthers; Corbin D Jones; Pei Fen Kuan; Benjamin G Vincent; Jonathan S Serody; Mitchell E Horwitz; Vincent T Ho; Steven Z Pavletic; Frances T Hakim; Kouros Owzar; Dadong Zhang; Bruce R Blazar; Christian W Siebel; Nelson J Chao; Ivan Maillard; Stefanie Sarantopoulos
Journal:  Blood       Date:  2017-08-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.